Kamada (KMDA) Return on Invested Capital Growth (3y) (2020 - 2026)

Kamada (KMDA) Return on Invested Capital Growth (3y) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC Growth (3y) (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 1.00
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -2.00
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 0.00
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn -
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 0.00
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn -
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 4.00
10 Kamada 399.49 Mn 326.34 Mn 19.12 Mn 538.00

Historic Data

Download Data
DateValue
Mar 31, 2026 538.00
Dec 31, 2025 557.00
Sep 30, 2025 494.00
Jun 30, 2025 502.00
Mar 31, 2025 1.00
Dec 31, 2023 13.00
Sep 30, 2023 -4.00
Jun 30, 2023 -21.00
Mar 31, 2023 -25.00
Dec 31, 2022 -22.00
Sep 30, 2022 -7.00
Jun 30, 2022 -21.00
Mar 31, 2022 -14.00
Dec 31, 2020 28.00
Sep 30, 2020 35.00
Jun 30, 2020 48.00
Mar 31, 2020 73.00